You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Systemic lupus erythematosus

Obinutuzumab for treating serologically active extra-renal lupus [TSID12285]

  • Awaiting development
  • Reference number: GID-TA11886
  • Expected publication date: TBC
  • Project information
  • Project documents

33503-Obinutuzumab-for-Serologically-Active-Extra-Renal-Lupus-V1.0-SEP2025-NON-CONF.pdf

Back to top